Skip to content

Illumina ILMN Inventories

Inventories at other companies

Revvity logo
RevvityRVTY
$387.51M+1.6%
Azenta logo
AzentaAZTA
$78.51M
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$79.92M-3.5%
Guardant Health logo
Guardant HealthGH
$83.85M+8.5%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$33.52M+60.7%
Natera, Inc. logo
Natera, Inc.NTRA
$70.72M+40.4%

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Gross profit$770.0M+10.8%
Operating income$245.0M+14.5%
Net income$207.0M-11.9%
EPS (diluted)$1.35-9.4%

Balance sheet

See full
Cash & equivalents$1.0B+11.3%
Total debt$1.9B-7.3%
Total equity$2.8B+25.7%
Total assets$6.7B+9.2%

Cash flow

See full
Operating cash flow$201.0M-14.1%
CapEx$39.0M+30.0%
Free cash flow$162.0M-20.6%

Valuation

See full
Market cap$29.2B+69.7%
Enterprise value$30.1B+63.8%
P/E35.4×+21.7×
P/S6.5×+2.5×

Profitability

See full
Gross margin66.4%-0.2pp
Operating margin19.6%
Net margin18.4%-11.0pp
FCF margin20.7%-3.3pp

Returns & leverage

See full
Return on equity32.4%-35.7pp
Debt / equity0.7×-0.2×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Illumina’s 8-K, filed July 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Illumina's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Illumina's inventories?
Illumina (ILMN) reported inventories of $629M in Q2 2026.
How has Illumina's inventories changed year-over-year?
Illumina's inventories decreased by 9.2% year-over-year, from $693M to $629M.
What is the long-term trend for Illumina's inventories?
Over 5 years (2020 to 2025), Illumina's inventories has grown at a -100.0% compound annual growth rate (CAGR), from $372M to $0.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.